Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/CLIC4_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/CLIC4_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/CLIC4_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/CLIC4_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/CLIC4_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Skin | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Skin/CLIC4_pca_on_diff_genes.png) | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/CLIC4_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001003829 | Skin | cSCC | response to metal ion | 132/4864 | 373/18723 | 3.11e-05 | 3.42e-04 | 132 |
GO:000206426 | Skin | cSCC | epithelial cell development | 84/4864 | 220/18723 | 4.33e-05 | 4.56e-04 | 84 |
GO:003508814 | Skin | cSCC | establishment or maintenance of apical/basal cell polarity | 26/4864 | 49/18723 | 4.78e-05 | 4.96e-04 | 26 |
GO:006124514 | Skin | cSCC | establishment or maintenance of bipolar cell polarity | 26/4864 | 49/18723 | 4.78e-05 | 4.96e-04 | 26 |
GO:000991324 | Skin | cSCC | epidermal cell differentiation | 78/4864 | 202/18723 | 5.12e-05 | 5.28e-04 | 78 |
GO:000188525 | Skin | cSCC | endothelial cell development | 30/4864 | 64/18723 | 2.50e-04 | 2.04e-03 | 30 |
GO:00070354 | Skin | cSCC | vacuolar acidification | 13/4864 | 24/18723 | 3.02e-03 | 1.67e-02 | 13 |
GO:000315824 | Skin | cSCC | endothelium development | 49/4864 | 136/18723 | 6.00e-03 | 2.95e-02 | 49 |
GO:005159217 | Skin | cSCC | response to calcium ion | 52/4864 | 149/18723 | 9.63e-03 | 4.31e-02 | 52 |
GO:0007163111 | Thyroid | PTC | establishment or maintenance of cell polarity | 115/5968 | 218/18723 | 1.15e-10 | 3.90e-09 | 115 |
GO:006056219 | Thyroid | PTC | epithelial tube morphogenesis | 141/5968 | 325/18723 | 7.52e-06 | 8.73e-05 | 141 |
GO:0002064112 | Thyroid | PTC | epithelial cell development | 101/5968 | 220/18723 | 8.53e-06 | 9.74e-05 | 101 |
GO:000188519 | Thyroid | PTC | endothelial cell development | 37/5968 | 64/18723 | 1.62e-05 | 1.70e-04 | 37 |
GO:0010038112 | Thyroid | PTC | response to metal ion | 157/5968 | 373/18723 | 1.80e-05 | 1.86e-04 | 157 |
GO:0003158111 | Thyroid | PTC | endothelium development | 62/5968 | 136/18723 | 5.45e-04 | 3.48e-03 | 62 |
GO:004544619 | Thyroid | PTC | endothelial cell differentiation | 55/5968 | 118/18723 | 5.64e-04 | 3.59e-03 | 55 |
GO:005159219 | Thyroid | PTC | response to calcium ion | 65/5968 | 149/18723 | 1.67e-03 | 9.16e-03 | 65 |
GO:003508810 | Thyroid | PTC | establishment or maintenance of apical/basal cell polarity | 26/5968 | 49/18723 | 1.68e-03 | 9.20e-03 | 26 |
GO:006124510 | Thyroid | PTC | establishment or maintenance of bipolar cell polarity | 26/5968 | 49/18723 | 1.68e-03 | 9.20e-03 | 26 |
GO:00070355 | Thyroid | PTC | vacuolar acidification | 15/5968 | 24/18723 | 1.95e-03 | 1.05e-02 | 15 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CLIC4 | SNV | Missense_Mutation | rs779954576 | c.257N>T | p.Thr86Met | p.T86M | Q9Y696 | protein_coding | deleterious(0.02) | probably_damaging(0.999) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CLIC4 | SNV | Missense_Mutation | novel | c.16N>A | p.Pro6Thr | p.P6T | Q9Y696 | protein_coding | deleterious_low_confidence(0.03) | benign(0.151) | TCGA-Q1-A5R2-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PR |
CLIC4 | SNV | Missense_Mutation | | c.647G>A | p.Gly216Asp | p.G216D | Q9Y696 | protein_coding | deleterious(0) | possibly_damaging(0.826) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CLIC4 | SNV | Missense_Mutation | | c.283C>A | p.Leu95Ile | p.L95I | Q9Y696 | protein_coding | deleterious(0.04) | probably_damaging(0.997) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CLIC4 | SNV | Missense_Mutation | novel | c.468N>G | p.Asn156Lys | p.N156K | Q9Y696 | protein_coding | tolerated(0.29) | benign(0.054) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD |
CLIC4 | SNV | Missense_Mutation | rs144375143 | c.617G>A | p.Arg206His | p.R206H | Q9Y696 | protein_coding | tolerated(0.06) | benign(0.009) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
CLIC4 | SNV | Missense_Mutation | | c.375N>A | p.Phe125Leu | p.F125L | Q9Y696 | protein_coding | deleterious(0.04) | benign(0.166) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
CLIC4 | SNV | Missense_Mutation | | c.109T>C | p.Phe37Leu | p.F37L | Q9Y696 | protein_coding | deleterious(0.04) | probably_damaging(0.92) | TCGA-D1-A167-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CLIC4 | SNV | Missense_Mutation | novel | c.307N>G | p.Lys103Glu | p.K103E | Q9Y696 | protein_coding | tolerated(0.11) | possibly_damaging(0.795) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CLIC4 | deletion | Frame_Shift_Del | | c.612delA | p.Lys204AsnfsTer11 | p.K204Nfs*11 | Q9Y696 | protein_coding | | | TCGA-AX-A3FT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |